Dividend aristocrats — S&P 500 stocks with 25 or more consecutive years of dividend increases — are supposed to be the safest income investments. But several members of this elite group are flashing warning signs. Here are three aristocrats under pressure and two alternatives offering better payout safety.
The setup
The S&P 500 Dividend Aristocrats index contains roughly 65 stocks. Most are financially sound. A handful, however, face deteriorating earnings, elevated payout ratios, or structural headwinds that could force dividend cuts. Earnings surprises and guidance revisions from Q1 2026 have brought three names into the danger zone.
Key numbers
| Stock | Yield | Payout Ratio | FCF Coverage | Consecutive Increases | Risk Level |
|---|---|---|---|---|---|
| 3M (MMM) | 2.1% | 78% | 0.9x | 66 years | High |
| Intel (INTC) | 1.2% | 165% | Negative | 31 years | Very High |
| Amcor (AMCR) | 4.8% | 72% | 1.1x | 31 years | Moderate |
| AbbVie (ABBV) | 3.5% | 54% | 1.7x | 12 years* | Low |
| Caterpillar (CAT) | 1.6% | 32% | 2.4x | 31 years | Low |
*AbbVie inherited Abbott Laboratories’ dividend streak following the 2013 spinoff.
What to watch
3M (MMM) faces $10 billion-plus in litigation settlements spanning combat earplug claims and PFAS environmental liabilities. Free cash flow coverage of the dividend has fallen below 1.0x — meaning the company is paying out more than it generates. While management maintains commitment to the 66-year streak, the math is becoming difficult. Watch for Q2 2026 earnings: if FCF remains below payout, a cut becomes likely.
Intel (INTC) pays a dividend it cannot afford. With a payout ratio exceeding 160% and negative free cash flow from massive capital expenditure commitments, Intel’s 31-year streak is in jeopardy. The foundry business is years from profitability. Management has signaled that dividends are under review. A reduction appears probable before 2027.
Amcor (AMCR) is not in immediate danger, but its 4.8% yield signals market concern. Packaging volume declines in Europe and margin pressure from resin costs are compressing earnings. The payout ratio sits at 72% — manageable but not comfortable. Any further earnings erosion puts the dividend at risk.
Bottom line
Income investors should run — not walk — away from Intel. The dividend math simply does not work. 3M warrants close monitoring; hold only if you accept meaningful cut risk. Amcor remains a hold but not a new buy at these levels.
For safer income, AbbVie offers a well-covered 3.5% yield with Humira biosimilar headwinds fading and a diversified pipeline. Caterpillar’s 1.6% yield may seem modest, but 32% payout coverage and a 2.4x FCF ratio mean this dividend is rock-solid with strong growth potential.
Stay ahead with our weekly newsletter
Get income investing insights, dividend safety screens, and market analysis delivered to your inbox every week. Subscribe to the free AlphaBetaStock newsletter — no spam, no hype, just actionable research for conservative investors.
